Register for our July 24 live deminar and see the features of the Cellometer Ascend hosted by our cell counting expert, Bill Rice. Register today! http://ms.spr.ly/6045l8LQ3
About us
Transforming innovation from target to cure. Revvity delivers end-to-end expertise and solutions from research discovery to development, and diagnosis to cure. Our scalable, end-to-end workflows are uniquely positioned to meet your needs – from basic research through to the development of new drugs. Our team introduces roughly 1,500 new life science antibodies, kits and reagents annually and 47 of the world's top 50 pharma companies use our discovery solutions and services to work towards finding novel therapeutics. Learn why here: www.revvity.com
- Website
-
http://www.revvity.com/
External link for Revvity for Life Sciences
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
Updates
-
Read the new peer-reviewed paper to learn how to simultaneously knockout multiple genes and integrated a transgene in T cells using the Pin-point™ base editing platform. http://ms.spr.ly/6047lPZR9 #BaseEditing #cellandgenetherapy #CGT #RevvUpResearch
-
-
We value the incredible work you do and want to learn from you. Submit your feedback on our #reagents, #platereaders, #highcontentimaging systems, or #radiometricdetector and be entered into monthly sweepstakes for a $100 Amazon eGift card. http://ms.spr.ly/6043YUThD
-
-
The mTOR pathway's impact on cellular and organismal physiology is seemingly infinite. Learn more about the mTOR pathway and browse our engineered HAP1 and cancer cell lines. Read our blog. http://ms.spr.ly/6042YAxhw
-
-
Gain precise molecular insights using radiometric detection. Transform #drugdiscovery & development with unmatched sensitivity. Explore further. http://ms.spr.ly/6046YWTlK #radiometricdetector #drugdevelopment
-
Discover how organ-on-chip models and advanced imaging techniques are revolutionizing predictive toxicology testing and facilitating the development of safer and more effective medicines. http://ms.spr.ly/6048YAIVm
-
-
Discover our versatile base editing platform that can be adapted to work with a variety of Type II and Type V nucleases. Learn more in our scientific poster. http://ms.spr.ly/6049lpC7B #BaseEditing #cellandgenetherapy #CGT #RevvUpResearch
-
-
Read our immune cell compound screening compendium to see why companies worldwide trust Revvity's preclinical services team, a US-based company with UK-based labs, for their projects. http://ms.spr.ly/6040YAxUs
-
-
Learn how cell line-derived control materials can enhance the reliability of your oncology assays in this white paper. http://ms.spr.ly/6040YASHY
-
-
Discover the power of EnVision Nexus™ featuring HTRF™ and LANCE™ no-wash #immunoassays for rapid, reproducible TR-FRET results in #drugdiscovery! http://ms.spr.ly/6041Yvqdc
-